Targeting XIST induced apoptosis of human osteosarcoma cells by activation of NF-kB/PUMA signal

被引:31
|
作者
Gao, Weiliang [1 ]
Gao, Jisheng [1 ]
Chen, Longying [2 ]
Ren, Yande [3 ]
Ma, Jinfeng [4 ]
机构
[1] 107 Hosp Peoples Liberat Army, Dept Spine Surg, Yantai 264000, Shandong, Peoples R China
[2] Linyi Cent Hosp, Dept Orthoped, Linyi, Shandong, Peoples R China
[3] Qingdao Univ, Affiliated Hosp, Dept Radiol, Qingdao, Shandong, Peoples R China
[4] Qingdao Univ, Affiliated Hosp, Dept Spine Surg, Qingdao, Shandong, Peoples R China
关键词
Osteosarcoma; long noncoding RNA X-inactive specific transcript; nuclear factor-kappa B; p53 upregulated modulator of apoptosis; Apoptosis; LONG NONCODING RNA; KAPPA-B; THERAPEUTIC TARGET; EXPRESSION; CANCER; PUMA; GENE; CHROMATIN; AXIS;
D O I
10.1080/21655979.2019.1631104
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The long noncoding RNA X-inactive specific transcript (XIST) plays vital roles in tumor progression. However, the underlying mechanisms remain unclear. This study investigated the effects and mechanisms of targeting XIST on osteosarcoma (OS) cells in vitro and in vivo. We used shRNA to knockdown XIST to evaluate cell growth and apoptosis in U2OS cells in vitro and xenograft formation in vivo. An observed relationship between XIST and the p53 upregulated modulator of apoptosis (PUMA) and nuclear factor-kappa B (NF-kB) pathway was further explored by using small interfering RNA (siRNA). Our results showed that suppression of XIST by short hairpin RNA (shRNA) impeded U2OS cell growth, induced apoptosis and lessened OS xenograft tumor growth. Targeting XIST increased NF-kB-dependent PUMA upregulation in U2OS cells. Upregulation of PUMA is correlated with suppression of XIST-induced apoptosis in U2OS cells. Therefore, inhibition of XIST could promote U2OS cell death via activation of NF-kB/PUMA pathways.
引用
收藏
页码:261 / 270
页数:10
相关论文
共 50 条
  • [1] Cellular specificity of IR-induced NF-kB activation in vivo and role of NF-kB in IR-induced lymphocyte apoptosis
    Meng, AM
    Yu, T
    Chen, G
    Brown, SA
    Thompson, JS
    Zhou, DH
    FASEB JOURNAL, 2002, 16 (04): : A315 - A315
  • [2] NF-kB is a potent inhibitor of TNF-induced apoptosis in human hepatoma cells.
    Malek, NP
    Plumpe, J
    Bock, CT
    Kubicka, S
    Manns, MP
    Trautwein, C
    HEPATOLOGY, 1997, 26 (04) : 560 - 560
  • [3] H. pylori induces apoptosis in parietal cells by activation of NF-kB
    Neu, B
    Randlkofer, P
    Neuhofer, M
    Gerhard, M
    Schapp, W
    Prinz, C
    GASTROENTEROLOGY, 2002, 122 (04) : A1 - A1
  • [4] CONSTITUTIVE ACTIVATION OF NF-KB IN HUMAN THYMOCYTES
    KORNER, M
    TARANTINO, N
    DEBRE, P
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (01) : 80 - 86
  • [5] Activation of the NF-kB RELB transcription factor in human endothelial cells
    Cota-Gomez, A
    Flores, N
    Flores, S
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S350 - S350
  • [6] NF-KB activation has a preventive effect on ox-LDL-induced apoptosis
    Watanabe, Y
    Nishio, E
    Kanda, Y
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R220 - R220
  • [7] Human thymic epithelial cells (TEC) induce apoptosis in T cells by inhibiting TCR-mediated NF-kB activation
    Galvin, JP
    Le, JRPT
    FASEB JOURNAL, 2003, 17 (07): : C219 - C219
  • [8] Targeting NF-KB Activation in Novel Intracranial Models of CNS Lymphoma
    Geng, Huimin
    Gao, Huaxin
    Kadoch, Cigall
    Lu, Ming
    Chen, Lingjing
    Anjum, Rana
    Drew, Lisa
    Degorce, Sebastien
    Dillman, Keith
    Mayo, Michele
    Anderson, Shawn
    Collins, Colin
    Lowell, Clifford A.
    Rubenstein, James L.
    BLOOD, 2016, 128 (22)
  • [9] Inhibition of NF-kB renders cells more vulnerable to apoptosis induced by amyloid β peptides
    Cardoso, SM
    Oliveira, CR
    FREE RADICAL RESEARCH, 2003, 37 (09) : 967 - 973
  • [10] Role of NF-kB in regulation of apoptosis of erythroid progenitor cells
    Sae-ung, N
    Muta, K
    Abe, Y
    Nawata, H
    Fucharoen, S
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 52 - 52